Patents by Inventor Deirdre McIntosh

Deirdre McIntosh has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11576886
    Abstract: The present invention relates to a construct comprising a C13 to C27 fatty acid non-covalently bound to a hydrophobic region of a carrier particle, methods of manufacture, and uses thereof.
    Type: Grant
    Filed: November 13, 2018
    Date of Patent: February 14, 2023
    Assignee: Polyrem Limited
    Inventors: Tony Davies, Deirdre McIntosh, Malcolm Weetman
  • Publication number: 20200323806
    Abstract: The present invention relates to a construct comprising a C13 to C27 fatty acid non- covalently bound to a hydrophobic region of a carrier particle, methods of manufacture, and uses thereof.
    Type: Application
    Filed: November 13, 2018
    Publication date: October 15, 2020
    Inventors: Tony Davies, Deirdre McIntosh, Malcolm Weetman
  • Publication number: 20140072530
    Abstract: We describe methods of treatment of HIV using proopiomelanocortin (POMC) and corticotropin releasing factor (CRF) peptides and their products, as well as uses of such peptides in the preparation and medicaments.
    Type: Application
    Filed: November 14, 2013
    Publication date: March 13, 2014
    Applicant: AIMSCO LIMITED
    Inventor: Deirdre McIntosh
  • Publication number: 20120208745
    Abstract: We describe methods of treatment of HIV using proopiomelanocortin (POMC) and corticotropin releasing factor (CRF) peptides and their products, as well as uses of such peptides in the preparation of medicaments.
    Type: Application
    Filed: April 19, 2012
    Publication date: August 16, 2012
    Inventor: Deirdre McIntosh
  • Publication number: 20090291060
    Abstract: We describe methods of treatment of HIV using proopiomelanocortin (POMC) and corticotropin releasing factor (CRF) peptides and their products, as well as uses of such peptides in the preparation of medicaments.
    Type: Application
    Filed: January 5, 2007
    Publication date: November 26, 2009
    Inventor: Deirdre McIntosh
  • Publication number: 20080207500
    Abstract: Analysis of a goat serum product with many therapeutic effects is described. The product is identified as containing proopiomelanocortin (POMC) and Corticotropin releasing factor (CRF) peptides, as well as breakdown products of these peptides. We describe methods of treatment of diseases including cancers, multiple sclerosis, and neural disorders using these peptides and their products, as well as medicaments including such peptides and methods of producing the peptides.
    Type: Application
    Filed: July 8, 2005
    Publication date: August 28, 2008
    Inventor: Deirdre McIntosh
  • Patent number: 6835395
    Abstract: Lipidic compositions with superior characteristics for in vivo delivery of oligodeoxynucleotides (ODN) can easily and efficiently be made in the form of small multilamellar vesicles. The compositions contain a population of nucleic acid-containing lipid vesicles in a liquid carrier, and at least a portion of the lipid vesicles are small multilamellar vesicles. The small multilamellar vesicles are made from a lipid component including 20-30 mol % of an ionizable amino lipid such as DODAP, and a steric barrier lipid such as PEG-CerC14; and an oligodeoxynucleotide contained in the lumen or interlamellar spaces of the small multilamellar vesicles. The ODN and lipid components are preferably present in the small multilamellar vesicles in a mole ratio of from 0.15 to 0.25.
    Type: Grant
    Filed: September 1, 2000
    Date of Patent: December 28, 2004
    Assignee: The University of British Columbia
    Inventors: Sean C. Semple, Sandra K. Klimuk, Troy O. Harasym, Nancy Dos Santos, Steven M. Ansell, Pieter R Cullis, Michael J. Hope, Peter Scherrer, Deirdre McIntosh, Kim F. Wong, Norbert Maurer